Mathematically, that's what our financials show. But if you
Mathematically, that's what our financials show. But if you dig further into our 10-K you'll note that we lost 97% of our revenues right at the end of 2011 as a result of the removal of the extended-release Lodrane product lines.
So when 2012 began for us, we were essentially starting from zero. The $4 million plus of revenues in the prior year did not exist when 2012 began. As Chris mentioned, most of this year's $2.4 million in revenues were from products and revenue streams that were launched during this year itself.
Almost $2.4 million in completely new revenues were created during this year. That's something that Elite has never achieved before. In fact, it took almost 20 years from its founding in 1990 all the way into 2009 for Elite to post annual revenues which first broke the $2 million barrier. It's really quite an accomplishment in 2012 in this regard.
These investments are required and they are being made as a result of Elite's creating the new and the growing financial streams which we are experiencing currently. If you read the K and the full financials, there's a few disclosures which I think deserve a special mention. Specifically, the patent approval, the bridge loan from our CEO , and the raising of additional capital.
All three of these things are related to each other. As Chris did, and I'm sure Jerry will mention, the approval of the patent related to our abuse resistant technology is one of the keystones of our future plans.
Elite Pharmaceuticals Inc (ELTP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...
Continue Reading
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...
Continue Reading
Top 5 Most Recently Viewed Articles
Transforming Health with Science-Backed Innovations UMeWorld Limited (OTC: UMEWF) is making significant strides in the realm of nutrition and consumer health. Recently, the company unveiled its plans to establish a Product Innovation & Development Center and appointed Dr. Zhang Guangxian to lead this initiative as Chief Scientist. Dr. Zhang, with an impressive two-decade...
Continue Reading
Celebrate Keynode's 7th Anniversary with Exclusive Benefits Keynode, a leading crypto staking platform, is thrilled to announce its 7th anniversary. To mark this significant milestone, the platform has launched a limited-time staking event designed to reward all of its users, new and existing, with appealing staking opportunities. This special event invites crypto...
Continue Reading
Columbia Banking System Declares Quarterly Dividend Columbia Banking System, Inc. (NASDAQ: COLB), the proud parent company of Umpqua Bank, has recently shared some good news with its shareholders. The company’s Board of Directors has officially approved a quarterly cash dividend of $0.36 per common share. This dividend represents a rewarding return for shareholders and...
Continue Reading
Understanding Recent Unusual Options Activity in META Recently, there has been a surge in interest surrounding Meta Platforms (NASDAQ: META), as notable investors are showing a bearish approach with their options trading. This activity could influence retail traders and investors alike. Insights from Trading History While the identity of these investors—whether...
Continue Reading
The Promising Future of Mobile VoIP Market Mobile Voice over Internet Protocol (VoIP) market has gained significant momentum, with a valuation of USD 31.2 billion recently. It's projected to surge to an estimated USD 73.4 billion by the end of the decade. As technology continues to evolve and consumer demands shift, this market showcases the increasing preference for...
Continue Reading